Biotech investor sets his sights on fibrosis

Biotech investor Claus Christiansen believes drugs to treat fibrosis will represent a huge market in the near future. His company Nordic Biosciences has discovered a biomarker that can predict the spread of lung fibrosis.

Photo: Jyllands-Posten

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles